Moreover, EFD has demonstrated that it is not a P-gp (P-glycoprotein) substrate; as a result, EFD is resistant to the P-gp efflux mechanism, which is used as a drug resistance process by many cancer cell lines. The gene discussed is PGP; the disease is cancer.